<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02484326</url>
  </required_header>
  <id_info>
    <org_study_id>14FCJJ01</org_study_id>
    <nct_id>NCT02484326</nct_id>
  </id_info>
  <brief_title>Clinical Risk Score Predicting the Cardiac Rupture in Patients With ST-elevation Myocardial Infarction</brief_title>
  <official_title>Development and Validation of a Clinical Risk Score Predicting the Cardiac Rupture in Patients With ST-elevation Myocardial Infarction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese PLA General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chinese PLA General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to validate a practical risk score to predict the mechanical
      complication of ST-elevation myocardial infarction (STEMI).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      STEMI patients chewed 300 mg aspirin and 600 mg clopidogrel in the emergency department,
      followed by oral 100 mg aspirin and 75mg clopidogrel daily for at least 12 months. STEMI
      patients received low molecular weight heparin (LMWH), β-blockers, and angiotensin converting
      enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARB) according to the STEMI
      guideline, unless there were contraindications to these drugs. Peripheral blood samples were
      collected from patients within 2 hours of admission for blood routines and blood biochemistry
      examinations. White blood cell counts and level of hemoglobin were assessed with automated
      cell counters via standard techniques. The investigators followed up patients in validation
      group for three month to observe the cardiac rupture events and other adverse cardiac events
      .
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Actual">January 2015</completion_date>
  <primary_completion_date type="Actual">January 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of cardiac rupture</measure>
    <time_frame>3 month</time_frame>
    <description>Pericardial tamponade or electromechanical dissociation accompanied with massive pericardial effusion is the indicator of cardiac rupture</description>
  </primary_outcome>
  <enrollment type="Actual">3779</enrollment>
  <condition>Cardiac Rupture</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Grouping by different risk stratification</intervention_name>
    <description>A simple risk score system based on 7 baseline clinical variables divided patients into four groups</description>
    <other_name>Risk stratification</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        ST-elevation myocardial infarction patients who were admitted from January 2012 to January
        2013
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        ST-elevation myocardial infarction: concurrence of symptoms (chest pain or symptoms
        compatible with acute heart failure or unexplained syncope) and electrocardiogram findings
        (new onset left bundle branch block or ST-segment elevation≥1 mm in ≥2 inferior leads or ≥2
        mm in ≥2 precordial leads)

        Exclusion Criteria:

        cancer mental illness
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Chinese People's Liberation Army General Hospital</name>
      <address>
        <city>Peking</city>
        <state>Beijing</state>
        <zip>100853</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <results_reference>
    <citation>Pouleur AC, Barkoudah E, Uno H, Skali H, Finn PV, Zelenkofske SL, Belenkov YN, Mareev V, Velazquez EJ, Rouleau JL, Maggioni AP, Køber L, Califf RM, McMurray JJ, Pfeffer MA, Solomon SD; VALIANT Investigators. Pathogenesis of sudden unexpected death in a clinical trial of patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. Circulation. 2010 Aug 10;122(6):597-602. doi: 10.1161/CIRCULATIONAHA.110.940619. Epub 2010 Jul 26.</citation>
    <PMID>20660803</PMID>
  </results_reference>
  <results_reference>
    <citation>French JK, Hellkamp AS, Armstrong PW, Cohen E, Kleiman NS, O'Connor CM, Holmes DR, Hochman JS, Granger CB, Mahaffey KW. Mechanical complications after percutaneous coronary intervention in ST-elevation myocardial infarction (from APEX-AMI). Am J Cardiol. 2010 Jan 1;105(1):59-63. doi: 10.1016/j.amjcard.2009.08.653.</citation>
    <PMID>20102891</PMID>
  </results_reference>
  <results_reference>
    <citation>Figueras J, Barrabés JA, Serra V, Cortadellas J, Lidón RM, Carrizo A, Garcia-Dorado D. Hospital outcome of moderate to severe pericardial effusion complicating ST-elevation acute myocardial infarction. Circulation. 2010 Nov 9;122(19):1902-9. doi: 10.1161/CIRCULATIONAHA.109.934968. Epub 2010 Oct 25.</citation>
    <PMID>20975001</PMID>
  </results_reference>
  <results_reference>
    <citation>López-Sendón J, Gurfinkel EP, Lopez de Sa E, Agnelli G, Gore JM, Steg PG, Eagle KA, Cantador JR, Fitzgerald G, Granger CB; Global Registry of Acute Coronary Events (GRACE) Investigators. Factors related to heart rupture in acute coronary syndromes in the Global Registry of Acute Coronary Events. Eur Heart J. 2010 Jun;31(12):1449-56. doi: 10.1093/eurheartj/ehq061. Epub 2010 Mar 15.</citation>
    <PMID>20231153</PMID>
  </results_reference>
  <results_reference>
    <citation>Jones BM, Kapadia SR, Smedira NG, Robich M, Tuzcu EM, Menon V, Krishnaswamy A. Ventricular septal rupture complicating acute myocardial infarction: a contemporary review. Eur Heart J. 2014 Aug 14;35(31):2060-8. doi: 10.1093/eurheartj/ehu248. Epub 2014 Jun 26. Review.</citation>
    <PMID>24970335</PMID>
  </results_reference>
  <results_reference>
    <citation>Qian G, Liu HB, Wang JW, Wu C, Chen YD. Risk of cardiac rupture after acute myocardial infarction is related to a risk of hemorrhage. J Zhejiang Univ Sci B. 2013 Aug;14(8):736-42. doi: 10.1631/jzus.B1200306.</citation>
    <PMID>23897793</PMID>
  </results_reference>
  <results_reference>
    <citation>Roberts WC, Burks KH, Ko JM, Filardo G, Guileyardo JM. Commonalities of cardiac rupture (left ventricular free wall or ventricular septum or papillary muscle) during acute myocardial infarction secondary to atherosclerotic coronary artery disease. Am J Cardiol. 2015 Jan 1;115(1):125-40. doi: 10.1016/j.amjcard.2014.10.004. Epub 2014 Oct 13. Review.</citation>
    <PMID>25456862</PMID>
  </results_reference>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 22, 2015</study_first_submitted>
  <study_first_submitted_qc>June 24, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 29, 2015</study_first_posted>
  <last_update_submitted>June 24, 2015</last_update_submitted>
  <last_update_submitted_qc>June 24, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 29, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chinese PLA General Hospital</investigator_affiliation>
    <investigator_full_name>Qian geng</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>ST-elevation myocardial infarction</keyword>
  <keyword>Cardiac rupture</keyword>
  <keyword>Risk assessment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Rupture</mesh_term>
    <mesh_term>ST Elevation Myocardial Infarction</mesh_term>
    <mesh_term>Heart Rupture</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

